sodium 3-cyanobenzenesulfinate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: sodium 3-cyanobenzenesulfinate
• 英文别名: sodium;3-cyanobenzenesulfinate
• 化学式: C₇H₄NO₂S*Na
• 分子量: 189.17
• InChiKey: ATMVDUXXBTXSPZ-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -2.2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  83.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  sodium 3-cyanobenzenesulfinate 在 四(三苯基膦)钯 、 potassium carbonate 、 三氯氧磷 作用下， 以 1,4-二氧六环 、 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 26.0h， 生成 3-((4-(4-chlorophenyl)-7-fluoroquinolin-3-yl)sulfonyl)benzonitrile
  参考文献：
  名称：

  Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications

  摘要：

  Negative allosteric modulators (NAM) of metabotropic glutamate receptor 5 (mGluR5) have been implicated as a potential pharmacotherapy for a number of psychiatric diseases, including anxiety and depression. Most of the mGluR5 NAM clinical candidates can be characterized by the central acetylenic moiety that connects the terminal pharmacophores. Identification of a sulfoquinoline hit via high throughput screening (HTS) followed by optimization provided a 4-phenyl-3-aryl-sulfoquinoline lead compound with the minimal pharmacophore. Optimization of the core and aryl appendages was performed by scanning and matrix libraries synthesized by the multiple parallel synthesis approach. Biological evaluation of matrix libraries provided a number of potent, metabolically stable, and in vivo active compounds. One of these compounds, 25 showed high efficacy and safety in preclinical in vivo models; this allowed its nomination as a novel, nonacetylenic mGluR5 NAM clinical candidate. Compound 25 was advanced to first-in-man trials for the treatment of psychiatric conditions.

  DOI：

  10.1021/acs.jmedchem.6b01858
• 作为产物：
  描述：

  3-氰基苯磺酰氯 在 碳酸氢钠 、 sodium sulfite 作用下， 以 水 为溶剂， 反应 12.0h， 生成 sodium 3-cyanobenzenesulfinate
  参考文献：
  名称：

  通过脱氧/异构化过程，可见光促进E-选择性合成α-氟-β-芳基烯基硫化物

  摘要：

  已经用宝石-二氟烯烃和亚磺酸钠以无过渡金属的方式建立了α-氟-β-芳基烯基硫的区域选择性合成。进行了一系列对照实验，证明了巯基和阴离子为拟议的中间体。值得注意的是，在不存在光引发剂的情况下，在绿光照射下实现了区域选择性的Z → E异构化。

  DOI：

  10.1039/d0cc08254f

文献信息

• [EN] NOVEL COMPOUNDS FOR MODULATION OF ROR-GAMMA ACTIVITY<br/>[FR] NOUVEAUX COMPOSÉS POUR LA MODULATION DE L'ACTIVITÉ ROR-GAMMA
  申请人：BIOGEN IDEC INC

  公开号：WO2014028669A1

  公开（公告）日：2014-02-20

  The present invention relates to aryl sulfones and related compounds that are modulators of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these modulators, and methods of modulating ROR-gamma receptors using them. Also provided are methods of using aryl sulfones and related compounds as modulators of ROR-gamma to treat ROR-gamma mediated diseases.

  本发明涉及芳基砜和相关化合物，它们是ROR-gamma受体的调节剂。该发明还提供包含这些调节剂的药物组合物，以及使用它们调节ROR-gamma受体的方法。还提供了使用芳基砜和相关化合物作为ROR-gamma调节剂治疗ROR-gamma介导疾病的方法。
• Electrochemical Radical–Radical Cross-Coupling Approach between Sodium Sulfinates and 2<i>H</i>-Indazoles to 3-Sulfonylated 2<i>H</i>-Indazoles
  作者：Wansoo Kim、Hun Young Kim、Kyungsoo Oh

  DOI：10.1021/acs.orglett.0c02144

  日期：2020.8.21

  A direct cross-coupling between sodium sulfinates and 2H-indazoles has been developed under electrochemical conditions. The utilization of a graphite anode and platinum cathode in an undivided cell with a constant current of 7 mA allowed the concurrent oxidations of sulfinates and 2H-indazoles to sulfonyl radical and radical cationic 2H-indazoles, facilitating the direct radical–radical coupling strategy

  在电化学条件下，已开发出亚磺酸钠和2 H-吲唑之间的直接交叉偶联。在恒定电流为7 mA的不分隔电池中利用石墨阳极和铂阴极可以使亚磺酸盐和2 H-吲唑同时氧化为磺酰基和自由基阳离子2 H-吲唑，从而促进了自由基与自由基的直接偶联反应生成3-磺酰化的2 H-吲唑衍生物。不含过渡金属和氧化还原试剂的合成方法应作为实现杂芳族化合物的有价值的合成工具。
• [EN] EPIMINOCYCLOALKYL(B)INDOLE DERIVATIVES AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS AND USES THEREOF<br/>[FR] DÉRIVÉS D'ÉPIMINOCYCLOALKYL(B)INDOLE UTILISÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR DE LA SÉROTONINE DE SOUS-TYPE 6 (5-HT6) ET LEURS UTILISATIONS
  申请人：ALBANY MOLECULAR RES INC

  公开号：WO2011044134A1

  公开（公告）日：2011-04-14

  The present invention relates to epiminocycloalkyl[b]indole derivatives as serotonin sub-type 6 (5-HT6) modulators, pharmaceutical compositions including these compounds, and methods of preparation and use thereof. These compounds are useful in the treatment of central nervous system disorders including obesity, metabolic syndrome, cognition, and schizophrenia. The subject compounds have the structure of formula (I), with the substituents being described herein.

  本发明涉及作为5-羟色胺亚型6（5-HT6）调节剂的环氨基环巴[b]吲哚衍生物，包括这些化合物的药物组合物，以及其制备和使用方法。这些化合物在治疗包括肥胖、代谢综合征、认知和精神分裂症在内的中枢神经系统疾病中具有用途。所述化合物具有式（I）的结构，其中取代基如本文所述。
• BENZOFURO[3,2-c] PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA
  申请人：GUZZO Peter R.

  公开号：US20120184531A1

  公开（公告）日：2012-07-19

  The present invention relates to benzofuro[3,2-c]pyridine and azepine analogs as serotonin sub-type 6 (5-HT 6 ) modulators, pharmaceutical compositions including these compounds, methods of preparation, and use thereof. These compounds are useful in the treatment of central nervous system disorders including obesity, metabolic syndrome, cognition, schizophrenia, attention deficit hyperactivity disorder, bipolar disorder, rare and orphan diseases, and sleep disorders. The subject compounds have the structure of formula (I) with the substituents being described herein.

  本发明涉及苯并呋喃[3,2-c]吡啶和氮杂环庚烯类似物作为5-羟色胺亚型6（5-HT6）调节剂，包括这些化合物的药物组合物，其制备方法以及使用方法。这些化合物在治疗包括肥胖、代谢综合征、认知障碍、精神分裂症、注意力缺陷多动障碍、躁郁症、罕见和孤儿疾病以及睡眠障碍在内的中枢神经系统疾病中是有用的。所述化合物具有如下式（I）的结构，其中所述取代基在此处描述。
• Regioselective molybdenum-catalyzed allylic substitution of tertiary allylic electrophiles: methodology development and applications
  作者：Muhammad Salman、Yaoyao Xu、Shahid Khan、Junjie Zhang、Ajmal Khan

  DOI：10.1039/d0sc01763a

  日期：——

  The first molybdenum-catalyzed allylic sulfonylation of tertiary allylic electrophiles is described. The method employs a readily accessible catalyst (Mo(CO)6/2,2′-bipyridine, both are commercially available) and represents the first example of the use of a group 6 transition metal-catalyst for allylic sulfonylation of substituted tertiary allylic electrophiles to form carbon–sulfur bonds. This atom

  描述了第三级烯丙基亲电试剂的第一钼催化的烯丙基磺酰化。该方法采用易于获得的催化剂（Mo（CO）6 / 2,2'-联吡啶，均可商购），并且是使用第6组过渡金属催化剂进行取代的叔烯丙基亲电子试剂的烯丙基磺酰化的第一个实例。形成碳硫键。这种原子经济且操作简单的方法，其特点是相对温和的条件，较宽的底物范围和出色的区域选择性，因此即使在后期功能化的情况下，也可以开辟一个新的平台来锻造砜部分，并为进一步衍生化提供了充足的机会通过传统的铃木交叉偶联反应。